22 January 2025 -- Espoo, Finland -- Medix Biochemica, a global leader in the supply of critical raw materials for the in vitro diagnostics (IVD) industry, announced the acquisition of CANDOR Bioscience GmbH, a Germany-based developer and manufacturer of premium immunoassay solutions.

22 January 2025 -- California, US -- Artificial, Inc, a technology company providing cloud-based solutions to streamline laboratory operations and accelerate life science discoveries, today announced proof of concept data demonstrating the Artificial Platform’s workflow and model integration capabilities in collaboration with NVIDIA’s BioNeMo, a generative AI platform for chemistry and biology.

22 January 2025 -- Chandigarh, India -- Venus Remedies, a premier player in the global pharmaceutical industry, has announced the successful renewal of its European Good Manufacturing Practices (EU-GMP) certification by Infarmed, the National Authority of Medicines and Health Products in Portugal.

21 January 2025 -- California, US -- Bio-Rad Laboratories, Inc, a global leader in life science research and clinical diagnostics products, today announced the launch of Vericheck ddPCR™ Empty-Full Capsid Kits for adeno-associated virus (AAV) serotypes 2 and 8, enabling determination of capsid titer, genome titer, and percentage of full capsids in purified or unpurified (crude lysate) samples.

21 January 2025 -- London, UK -- A social networking platform aimed to improve patient care across the globe is launching in the UK today (21 January).The app – called SurgeOn – has already seen success in the US with over 17,000 physicians signed up and now it’s available for the NHS.

21 January 2025 -- Ontario, Canada, and Göttingen, Germany -- The life science group Sartorius and McMaster University today opened a new bioprocessing automation lab at the university’s Faculty of Engineering in Hamilton, Ontario. The state-of-the-art, 1,600-square-foot research facility was created complementing a substantial contribution of advanced biomanufacturing equipment from Sartorius, a long-standing partner of the university.

21 January 2025 -- Genas, France -- CLAYENS Healthcare, a leading innovator in plastic solutions for the healthcare industry, has achieved a significant breakthrough with its cutting-edge surface functionalization technology. This method gives antibacterial properties to plastic surfaces without the use of chemicals, by replicating micro and nano patterns from the cavities during injection molding.

20 January 2025 -- Reichenau, Germany -- Cormica, a global leader in life sciences testing and consulting, has completed the acquisition of Zwisler Laboratorium, a premier provider of laboratory services headquartered in Reichenau, Germany.

16 January 2025 -- London, UK -- The med-tech sector is one of the most important contributors to the UK’s economy, with an estimated market size of approximately £25 billion and the source of over 100,000 jobs across the country. But beyond its important position within the UK’s economy, it plays an even more critical part in driving innovation in the development of cutting-edge technologies that attract wider domestic and international investment.

16 January 2025 -- Warrington, UK -- United Kingdom National Nuclear Laboratory (UKNNL) and Medicines Discovery Catapult (MDC) have received funding from UK Research and Innovation (UKRI) to drive the development of innovative approaches for new cancer treatments.

15 January 2025 -- Massachusetts, US -- Lyndra Therapeutics, a clinical-stage biopharmaceutical company pioneering long-acting oral therapies, today announced a strategic collaboration with Thermo Fisher Scientific Inc., the world leader in serving science, in which Thermo Fisher will provide global clinical research and commercial manufacturing services to Lyndra for its long-acting oral therapies.

15 January 2025 -- New York, US -- Join thousands of industry professionals at INTERPHEX, the premier pharmaceutical and biotechnology event taking place April 1-3, 2025, at the Javits Center in NYC. Here, attendees gain direct access to the tools they need to effectively accelerate their drug-to-market journey.